ALTS vs AMCI

ALTS exhibits severe financial distress signals, with a Piotroski F-Score of 2/9 indicating poor operational and financial health. The company's Altman Z-Score is unavailable, but its negative ROA (-1.71%), negative operating margin (-218.34%), and extremely low current ratio (0.80) suggest high bankruptcy risk. Despite strong revenue growth (53.3% YoY), profitability remains elusive, and the stock trades at a steep Price/Sales of 6.85, far above its low Price/Book of 0.11. The 52-week price range ($1.08–$10.95) and 5-year decline of 82.8% reflect deep investor skepticism, despite a single 'strong_buy' analyst recommendation.

AMCI's Piotroski F-Score of 5/9 indicates a stable but not strong financial health, with no Altman Z-Score available to assess bankruptcy risk. The company exhibits high profitability margins (23.64% profit margin, 45.62% operating margin) but suffers from severe revenue contraction (-52.60% YoY) and negative ROA (-14.92%), signaling deteriorating asset efficiency. Valuation multiples are extremely elevated (Price/Book: 21.31, Price/Sales: 26.12), suggesting the stock trades at a significant premium despite declining growth. Insider selling of $3.08M in the last 6 months further undermines confidence, and the lack of analyst coverage or target prices reflects market skepticism.